Healthcare
Discover news, funding updates, regulatory changes, and sector insights impacting the health care industry in India.
Healthcare
How will healthcare delivery drive innovation in pharma? Find out at VCCircle Healthcare Investment Forum 2014; register now
With healthcare delivery taking the centre stage to drive innovations in healthcare products including pharma, medical ......
Healthcare
Cipla buying two plants owned by promoter's private firm Okasa for $17M
Medispray Laboratories Private Limited, a wholly owned subsidiary of Mumbai-based drugmaker Cipla Ltd, is acquiring two manufacturing units of private ......
Healthcare
Venus Remedies looking to raise $20M through QIP
Chandigarh-based listed pharma company Venus Remedies Limited, is looking to raise funds for marketing and other purposes, a top executive ......
Healthcare
Diagnostics and genomic research firm GeneOmbio scouting for investors
Pune-based GeneOmbio Technologies Pvt. Ltd, a molecular diagnostics and genomic research company that is an associate firm of public listed ......
Healthcare
Is consolidation the way forward for Indian healthcare delivery services? Find out at VCCircle Healthcare Investment Summit 2014; register now
Healthcare delivery services in India have drawn investors’ interest in the recent past and have witnessed some big-......
Healthcare
Medical tourism industry in India to reach $3.9B this year, says report
The medical tourism market in India is projected to hit $3.9 billion mark this year having grown at a compounded ......
Healthcare
CCI says Sun-Ranbaxy deal may hit competition
Launching the first-ever public scrutiny of an M&A deal in India, fair trade watchdog CCI today said it has prima ......
Healthcare
Trivitron aims at Rs700Cr revenues in FY15
Medical technology firm Trivitron Healthcare is aiming for over 25 per cent increase in revenues to Rs 700 crore in ......
Healthcare
Sun-Ranbaxy deal: CCI raises concerns about molecules market
The Competition Commission, which has put the multi-billion dollar Sun-Ranbaxy deal for public scrutiny, today said the major issue is ......
Healthcare
Piramal shutting drug discovery unit, forming 51:49 specialty fluorochemicals JV
Piramal Enterprises, which sold off its domestic formulations business to Abbott in a multi-billion dollar deal a few years ago, ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News